Nijmegen breakage syndrome protein (NBN) causes resistance to methylating anticancer drugs such as temozolomide. (Q39664744)
Jump to navigation
Jump to search
scientific article published on 20 August 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Nijmegen breakage syndrome protein (NBN) causes resistance to methylating anticancer drugs such as temozolomide. |
scientific article published on 20 August 2010 |
Statements
Nijmegen breakage syndrome protein (NBN) causes resistance to methylating anticancer drugs such as temozolomide (English)
Marcus Eich
Grigory L Dianov
Martin Digweed